HDAC family members are often overexpressed in human cancers (98), histone H4 is commonly deacetylated in human primary malignancies (99), and low acetylation of histone H3 is a predictor of poor outcomes in pancreatic, breast, gastric, ovarian, prostate, and lung cancers (100, 101). This evidence concerns the gene HDAC9 and lung cancer.